ロード中...
EZH2 overexpression is associated with poor prognosis in patients with glioma
Previous studies have investigated the prognostic value of enhancer of zeste homolog 2 (EZH2) expression in patients with glioma but conclude contradictory results. We aimed to comprehensively evaluate the prognostic role of EZH2 in glioma by meta-analysis. The databases of PubMed, Embase and Web of...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352178/ https://ncbi.nlm.nih.gov/pubmed/27880940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13478 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|